Patients with acromegaly provide a unique challenge to endocrine clinicians. Shlomo Melmed, MB, ChB, discusses the latest breakthroughs in treating these patients which includes newly approved pharmaceuticals in his session, “Update on Acromegaly: Treatment Based on the New Guidelines.” This year, the Endocrine Society’s Clinical Endocrinology Update (CEU) will take place online as the COVID-19...
CEU Preview: Challenging Cases in Lipid Management with Lisa Tannock, MD
Next month, the Endocrine Society’s Clinical Endocrinology Update will kick off in Miami, during which attendees will hear about the latest breakthroughs in patient care, as well as those cases that may prove difficult for clinicians. One such session is Lisa Tannock’s Meet-the-Professor presentation on Thursday, September 5, titled “Challenging Cases in Lipid Management.” Cardiovascular...CEU Preview: Optimizing Testosterone Therapy for the Individual Patient
In his talk, “Testosterone Replacement Modalities: Pros, Cons, and Their Correct Use,” Shehzad Sultan Basaria, MD, will discuss the benefits and drawbacks of various forms of treatments so clinicians can better inform their patients with hypogonadism. By now, the controversy surrounding testosterone therapy and the shady advertising schemes promulgating the idea of “andropause” in aging... The advent of newer — often very expensive — drugs has driven up the cost of care for diabetes. But older, less expensive medications can often still get the job done. Treating diabetes with lower-cost drugs might not only help a patient’s pocketbook, they might benefit the patient’s health as well. That will be one...CEU PREVIEW: Graves’ Anatomy: Transatlantic Differences in Treating Graves’ Hyperthyroidism
Disagreements abound in treating Graves’ hyperthyroidism from the U.S. to Europe as different treatment protocols take precedence. In both Seattle and Miami, “Diagnosis and Management of Graves’ Hyperthyroidism” will demonstrate these conflicting practices and the progress that has been achieved. Graves’ disease – the most common cause of hyperthyroidism – affects between 1% and 1.5%...
